← Back to headlines
Stifel Cuts Medtronic (MDT) Target to $95 Citing MiniMed IPO Effects
Stifel has lowered its price target for Medtronic (MDT) to $95, attributing the adjustment to the anticipated effects of the MiniMed IPO.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Amazon's First Customer Receipt Goes Viral, Bezos and Musk React
just now
Manila Water Deploys Tankers to Aid Maynilad After Pipe Break
just now
Manila Water Assists Maynilad with Tankers After Pipe Breakage in Tondo
just now
Philippine DOE Official Admits Fuel Price Adjustments Lead to Cartel-like Behavior
just now